ORIGINAL ARTICLE |
|
Year : 2014 | Volume
: 7
| Issue : 1 | Page : 44-47 |
|
Role of suprascapular nerve block in chronic shoulder pain: A comparative study of 60 cases
Anil Salgia, Tushar Agarwal, Subhash Rajendra Puri, Sahil Sanghi, Ashutosh Mohapatra
Departmnet of Orthopaedics, Padmashree Dr. D. Y. Patil Medical College, Hosptial and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, India
Correspondence Address:
Anil Salgia Department of Orthopaedics, Padmashree Dr. D. Y. Patil Medical College, Pimpri, Pune - 411 018 India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/0975-2870.122771
|
|
Background: Suprascapular nerve block using anatomical landmark has been shown to be a safe and effective treatment for chronic shoulder pain from rheumatoid and degenerative arthritis. This can be performed as an outpatient procedure that reduces pain and disability. Aims and Objectives: To access efficacy of suprascapular nerve block in chronic shoulder pain. To compare results between placebo and use of methyl prednisolone with bupivacaine for nerve block . Materials and Methods: 60 patients with chronic shoulder pain were taken up for the trial. In the study group, all patients received the block through the anatomical landmark approach, with a single sitting suprascapular nerve block. On randomized basis, 30 patients were given 10 ml of 0.5% bupivacaine and 40 mg of methyl prednisolone acetate (depo medrol) to block the suprascapular nerve. Another 30 patients were injected with 11 ml of 0.9% saline. Patients were followed up on 2 nd day, 7 th day, and 21 st day and 3 months for the status of relief of pain and improvement of movement of joint. Results: Evaluation of the efficacy of the block was achieved by comparing verbal pain scores and improvement in range of movements at 2, 7, 21 days and 3 months after the injection. Significant pain relief is defined as improvement of more than 70% on verbal and visual analog pain scale scores. Results were consistent with VAS score of pain. Maximum improvement was noted in the bupivacaine+methyl prednisolone mixed group. Conclusion: The result of this study shows a clear benefit of methyl prednisolone + bupivacaine for suprascapular nerve block in cases of chronic shoulder pain. There was statistically and clinically significant reduction in pain and improvement in range of movements. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|